AMG National Trust Bank bought a new position in shares of Humana Inc. (NYSE:HUM - Free Report) during the 4th quarter, according to its most recent disclosure with the SEC. The institutional investor bought 5,939 shares of the insurance provider's stock, valued at approximately $1,510,000.
Several other large investors have also recently added to or reduced their stakes in HUM. FPC Investment Advisory Inc. purchased a new stake in Humana during the 4th quarter worth approximately $27,000. Centricity Wealth Management LLC purchased a new stake in Humana during the 4th quarter worth approximately $30,000. Ashton Thomas Securities LLC purchased a new stake in Humana during the 3rd quarter worth approximately $31,000. Atwood & Palmer Inc. increased its stake in Humana by 64.5% during the 4th quarter. Atwood & Palmer Inc. now owns 153 shares of the insurance provider's stock worth $39,000 after buying an additional 60 shares during the period. Finally, Kestra Investment Management LLC purchased a new stake in shares of Humana in the 4th quarter valued at approximately $49,000. 92.38% of the stock is owned by hedge funds and other institutional investors.
Analysts Set New Price Targets
HUM has been the topic of a number of recent analyst reports. Piper Sandler increased their price objective on shares of Humana from $270.00 to $288.00 and gave the company a "neutral" rating in a research report on Wednesday, January 15th. Morgan Stanley dropped their target price on shares of Humana from $301.00 to $285.00 and set an "equal weight" rating on the stock in a research report on Wednesday, February 12th. StockNews.com downgraded shares of Humana from a "buy" rating to a "hold" rating in a research report on Wednesday, March 5th. Barclays increased their target price on shares of Humana from $255.00 to $270.00 and gave the company an "equal weight" rating in a research report on Thursday, February 13th. Finally, Truist Financial increased their target price on shares of Humana from $260.00 to $290.00 and gave the company a "hold" rating in a research report on Monday, January 6th. Twenty analysts have rated the stock with a hold rating and five have issued a buy rating to the company's stock. According to MarketBeat, the company has an average rating of "Hold" and an average price target of $285.68.
Read Our Latest Stock Analysis on HUM
Insider Transactions at Humana
In related news, insider Timothy S. Huval sold 3,703 shares of the business's stock in a transaction dated Tuesday, December 31st. The shares were sold at an average price of $256.26, for a total transaction of $948,930.78. Following the sale, the insider now owns 8,181 shares of the company's stock, valued at approximately $2,096,463.06. The trade was a 31.16 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Company insiders own 0.32% of the company's stock.
Humana Stock Performance
Shares of HUM stock traded down $1.04 during mid-day trading on Tuesday, hitting $250.21. The stock had a trading volume of 1,387,813 shares, compared to its average volume of 1,676,635. Humana Inc. has a fifty-two week low of $213.31 and a fifty-two week high of $406.46. The firm has a market cap of $30.19 billion, a PE ratio of 25.15, a PEG ratio of 2.05 and a beta of 0.57. The company has a debt-to-equity ratio of 0.68, a current ratio of 1.76 and a quick ratio of 1.76. The company's 50-day simple moving average is $271.67 and its 200-day simple moving average is $281.65.
Humana (NYSE:HUM - Get Free Report) last released its earnings results on Tuesday, February 11th. The insurance provider reported ($2.16) EPS for the quarter, topping the consensus estimate of ($2.26) by $0.10. Humana had a net margin of 1.02% and a return on equity of 11.70%. Sell-side analysts anticipate that Humana Inc. will post 16.47 earnings per share for the current year.
Humana Dividend Announcement
The company also recently announced a quarterly dividend, which will be paid on Friday, April 25th. Stockholders of record on Friday, March 28th will be paid a $0.885 dividend. This represents a $3.54 annualized dividend and a dividend yield of 1.41%. The ex-dividend date is Friday, March 28th. Humana's dividend payout ratio (DPR) is presently 35.58%.
Humana Profile
(
Free Report)
Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.
Featured Articles

Before you consider Humana, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Humana wasn't on the list.
While Humana currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.